Philadelphia, PA, United States of America

Matias Gabriel Hochman

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignees: Shuntcheck, Inc., Children's Medical Center Corporation. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matias Gabriel Hochman. Retrieved from https://idiyas.com/inventor/matias-gabriel-hochman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Matias Gabriel Hochman: Innovator in Cerebrospinal Fluid Shunt Technology

Introduction

Matias Gabriel Hochman is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical technology, particularly in the area of cerebrospinal fluid (CSF) shunt systems. With a total of 3 patents to his name, Hochman's work focuses on improving the functionality and assessment of CSF shunt systems.

Latest Patents

Hochman's latest patents include a "CSF shunt flow evaluation apparatus and method using a conformable expanded dynamic range thermosensor." This innovative apparatus utilizes thermal dilution to detect a wide range of flow rates and flow status in CSF shunt systems. The design incorporates a large cold source and a specially constructed thermosensor pad, allowing for accurate detection of very low levels of CSF flow. Additionally, the method includes adjustments for varying shunt catheter depths and features a software error check to ensure proper sensor-to-skin contact.

Another significant patent is the "CSF shunt flow enhancer, method for generating CSF flow in shunts and assessment of partial and complete occlusion of CSF shunt systems." This apparatus generates flow in CSF shunt systems by vibrating components or applying cyclical pressure. It provides a quick assessment of shunt patency based on hydraulic resistance, offering a more objective measure of shunt obstruction compared to traditional methods.

Career Highlights

Hochman has worked with several companies, including Shuntcheck, Inc. and Children's Medical Center Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for CSF shunt systems.

Collaborations

Hochman has collaborated with notable individuals in his field, including Marek Swoboda and Mark Evan Mattiucci. These partnerships have likely enhanced his research and development efforts in medical technology.

Conclusion

Matias Gabriel Hochman is a pioneering inventor whose work in cerebrospinal fluid shunt technology has the potential to significantly improve patient outcomes. His innovative patents and collaborations reflect his commitment to advancing medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…